Clarithromycin

Clarithromycin is a semi-synthetic macrolide antibiotic that inhibits bacterial 50S ribosomal protein synthesis, widely used for respiratory tract infections, H. pylori eradication combination regimens and atypical mycobacterial disease. Simson Pharma's Clarithromycin reference standard and impurities support the high-volume compendial testing this major macrolide antibiotic demands.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Clarithromycin Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Clarithromycin
Clarithromycin EP Impurity C
Clarithromycin 9-Oxime
Clarithromycin EP Impurity D
Clarithromycin EP Impurity E
Clarithromycin EP Impurity H
Clarithromycin EP Impurity I
Clarithromycin EP Impurity L
Clarithromycin EP Impurity M
Clarithromycin EP Impurity N
Clarithromycin EP Impurity K
Clarithromycin EP Impurity O
Clarithromycin EP Impurity G
Clarithromycin Mixture of Impurity O & Impurity G
Clarithromycin EP Impurity A
Clarithromycin EP Impurity B
Clarithromycin EP Impurity F
Clarithromycin EP Impurity P
Clarithromycin EP Impurity Q
Clarithromycin Impurity 1
N-Nitroso-N-Desmethyl-Clarithromycin
Clarithromycin EP Impurity J
Clarithromycin EP Impurity R
Clarithromycin Impurity 3
6-O-Methylerythromycin A 9-(E)-O-(1-isopropoxycyclohexyl)-oxime
Clarithromycin form II
14(S)-Hydroxy Clarithromycin

Metabolites

(14R)-14-Hydroxy Clarithromycin

Isotope Labelled Compounds

Clarithromycin-13C-D3
Clarithromycin D3
N-nitroso desmethyl Clarithromycin 13CD3